Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 3
2008 1
2010 2
2012 1
2013 2
2014 2
2015 4
2016 6
2018 8
2019 3
2020 7
2021 1
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
Ndembe G, Intini I, Moro M, Grasselli C, Panfili A, Panini N, Bleve A, Occhipinti M, Borzi C, Garassino MC, Marabese M, Canesi S, Scanziani E, Sozzi G, Broggini M, Ganzinelli M. Ndembe G, et al. Among authors: marabese m. J Exp Clin Cancer Res. 2024 Jan 2;43(1):6. doi: 10.1186/s13046-023-02933-5. J Exp Clin Cancer Res. 2024. PMID: 38163906 Free PMC article.
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.
Mendogni P, Affatato R, Cabri E, Chiappa M, Ndembe G, Tosi D, Del Gobbo A, Fratelli M, Pardini E, Petrini I, Rosso L, Broggini M, Marabese M. Mendogni P, et al. Among authors: marabese m. J Exp Clin Cancer Res. 2022 Dec 14;41(1):343. doi: 10.1186/s13046-022-02554-4. J Exp Clin Cancer Res. 2022. PMID: 36517829 Free PMC article.
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
Ndembe G, Intini I, Perin E, Marabese M, Caiola E, Mendogni P, Rosso L, Broggini M, Colombo M. Ndembe G, et al. Among authors: marabese m. Front Oncol. 2022 May 11;12:889826. doi: 10.3389/fonc.2022.889826. eCollection 2022. Front Oncol. 2022. PMID: 35646638 Free PMC article. Review.
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Borzi C, Ganzinelli M, Caiola E, Colombo M, Centonze G, Boeri M, Signorelli D, Caleca L, Rulli E, Busico A, Capone I, Pastorino U, Marabese M, Milione M, Broggini M, Garassino MC, Sozzi G, Moro M. Borzi C, et al. Among authors: marabese m. J Thorac Oncol. 2021 Aug;16(8):1298-1311. doi: 10.1016/j.jtho.2021.04.005. Epub 2021 Apr 19. J Thorac Oncol. 2021. PMID: 33887464 Free article.
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy.
Alvisi MF, Ganzinelli M, Linardou H, Caiola E, Lo Russo G, Cecere FL, Bettini AC, Psyrri A, Milella M, Rulli E, Fabbri A, De Maglie M, Romanelli P, Murray S, Ndembe G, Broggini M, Garassino MC, Marabese M. Alvisi MF, et al. Among authors: marabese m. J Clin Med. 2020 Jul 30;9(8):2438. doi: 10.3390/jcm9082438. J Clin Med. 2020. PMID: 32751518 Free PMC article.
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial.
Vernieri C, Ganzinelli M, Rulli E, Farina G, Bettini AC, Bareggi C, Rosso L, Signorelli D, Galli G, Lo Russo G, Proto C, Moro M, Indraccolo S, Busico A, Sozzi G, Torri V, Marabese M, Massimo B, Garassino MC. Vernieri C, et al. Among authors: marabese m. ESMO Open. 2020 May;5(3):e000748. doi: 10.1136/esmoopen-2020-000748. ESMO Open. 2020. PMID: 32467099 Free PMC article. Clinical Trial.
42 results